Skip to main content
Rural Health Information Hub

Alkermes Inspiration Grants

This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.

Sponsor
Alkermes, Inc.
Deadlines
Jul 15, 2022
Purpose

Alkermes Inspiration Grants provide funding to organizations working to address the needs of people living with addiction, serious mental illness, or cancer. Priority is given to proposals targeting historically under-resourced or underrepresented communities.

Areas of interest include but are not limited to:

  • New and innovative programs to address the needs of people affected by alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder, melanoma or ovarian cancer
  • Enhance support or resources for the population of focus, such as helplines and mobile outreach
  • Innovative efforts to meet educational needs of patients, families, and caregivers in under-resourced or underrepresented communities
  • Education and support for people living with addiction and/or mental illness to return to work and/or reenter society from criminal justice settings
Eligibility

501(c)(3) nonprofit organizations that are not engaged in the practice of healthcare (including counseling services) are eligible to apply.

Geographic coverage
Nationwide
Amount of funding

Award amounts have typically ranged from $25,000 to $75,000.

Application process

Application guidance and a link to the online application system are available on the program website.

Tagged as
Alcohol use · Cancer · Criminal justice system · Educational attainment · Employment and unemployment · Illicit drug use · Mental health · Prescription drug misuse · Substance use and misuse



For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.